Glucotrack Receives Nasdaq Delisting Notice
Nasdaq has notified Glucotrack, Inc. that its securities will be delisted following a failure to maintain the minimum bid price requirement.
Stocks · News reference
Glucotrack Issues Senior Secured Convertible Notes
Glucotrack, Inc. has issued $2.56 million in senior secured convertible notes in exchange for $2 million in cash.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-10-29 AccNo: 0001493152-26-049299 Size: 208 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Glucotrack Subsidiary Lokahi Therapeutics Secures First Fee-for-Service Partnership
Glucotrack, Inc. shares rose following the announcement that its subsidiary, Lōkahi Therapeutics, has entered into its first external, fee-for-service partnership.
GlucoTrack Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.81%
Glucotrack Announces 1-for-2 Reverse Stock Split
Glucotrack, Inc. is set to implement a 1-for-2 reverse stock split, with trading on a split-adjusted basis beginning October 26, 2026.
Glucotrack Announces 1-For-2 Reverse Stock Split, Effective Oct. 26